Real World Date (RWD) Quality considerations for regulatory purposes

3.50pm – 4.10pm GMT, 6 November 2024 ‐ 20 mins

Presentation

Session Three: Data, digital technologies and real-world evidence

Session Chair: Kathy Williams, Head of Global Regulatory Policy and Intelligence, AstraZeneca, and Vice-Chair, BIA Regulatory Affairs Advisory Committee